Technological watch

DuPont Announces New Brand Name for Its Silicone Healthcare Solutions

DuPont introduces DuPont™ Liveo™, a new brand name for its extensive range of silicone healthcare solutions. Inspired by the terms “live” and “to be alive,” the new Liveo™ brand name reflects DuPont Healthcare’s drive to create next-generation, innovative solutions that can help patients live life to the fullest.
Commitment in Healthcare and Renewed Energy
More than a name change, the Liveo™ brand reinforces DuPont’s commitment in healthcare and renewed energy to build on more than 70 years of , regulatory and manufacturing know-how, and application expertise.
The Liveo™ brand product line includes for single-use systems in biopharma processing, transdermal and topical drug delivery systems, medical adhesives for advanced wound care and ostomy care and wearables, silicone elastomers for a wide range of specialty , anti-flatulent active pharmaceutical ingredients, silicone antifoams, coating, fluids, emulsions and much more. The Liveo™ product line continues to be manufactured at the DuPont Healthcare Industries Materials Site (HIMS) in Hemlock, Michigan, USA, which is an ISO 9001:2015 and ISO 14000 registered site and FDA registered utilizing GMPs.
“As the new name for the longest legacy in healthcare applied silicones brought by DOW CORNING™, Liveo™ stands for smarter healthcare and positive patient outcomes,” says DuPont™ Liveo™ Healthcare global marketing manager Jennifer Gemo Mathis.
Same Packaging and Product Offering
Historically marketed with a DOW CORNING™ or SILASTIC™ trade name, the product offering and packaging material are not changing, and all locations will continue to manufacture the same products, using the same rigorous processes and quality oversight as before. Looking ahead, the Liveo™ brand will reinforce DuPont’s competitive advantages and leadership positions in three key healthcare markets – Biopharmaceutical Processing, Pharmaceutical Solutions and Medical Devices.
We are making significant investments in both capital and resources to strengthen our strategic capabilities to support our customers’ leadership in key healthcare industry market segments, and we are particularly proud of the contribution that our teams and products have provided to our customers without disruptions during the COVID-19 pandemic outbreak,” says DuPont™ Liveo™ Healthcare Global Business Director Eugenio Toccalino.
Dedicated to healthcare, DuPont™ Liveo™ is part of the DuPont Transportation & Industrial business unit (DuPont T&I).

Publication date: 17/09/2020

Omnexus (news)


This project has received funding from the Bio Based Industries Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme under grant agreement No 837761.